A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls-Reference-Cited by-同舟云学术

A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls

Published:2016-11-28 Issue:11 Volume:11 Page:e0167087
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wadman Renske I.,Stam Marloes,Jansen Marc D.,van der Weegen Yana,Wijngaarde Camiel A.,Harschnitz Oliver,Sodaar Peter,Braun Kees P. J.,Dooijes Dennis,Lemmink Henny H.,van den Berg Leonard H.,van der Pol W. Ludo

Funder

Prinses Beatrix Spierfonds

Stichting Spieren voor Spieren

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference72 articles.

1. Identification and characterization of a spinal muscular atrophy-determining gene;S Lefebvre;Cell,1995

2. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy;CL Lorson;Proc Natl Acad Sci U S A,1999

3. How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches;B Wirth;Curr Opin Genet Dev,2013

4. The survival of motor neuron (SMN) protein interacts with the mRNA-binding protein HuD and regulates localization of poly(A) mRNA in primary motor neuron axons;C Fallini;J Neurosci,2011

5. SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination;DY Zhao;Nature,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into spinal muscular atrophy from molecular biomarkers;Neural Regeneration Research;2024-06-26

2. Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era;Frontiers in Neurology;2023-11-13

3. Molecular markers of disease severity and response to nusinersen therapy in 5q spinal muscular atrophy (literature review);Neuromuscular Diseases;2023-10-30

4. Identifying Biomarkers of Spinal Muscular Atrophy for Further Development;Journal of Neuromuscular Diseases;2023-09-08

5. Innovating spinal muscular atrophy models in the therapeutic era;Disease Models & Mechanisms;2023-09-01